Optimizing retention strategies for opioid use disorder pharmacotherapy: The retention phase of the CTN-0100 trial (RDD)

Shulman, M., Meyers-Ohki, S., Novo, P., Provost, S., Ohrtman, K., Van Veldhuisen, P., Oden, N., Otterstatter, M., Bailey, G. L., Liu, D., Rotrosen, J., Weiss, R. D., & Nunes, E. V. (2025). Optimizing retention strategies for opioid use disorder pharmacotherapy: The retention phase of the CTN-0100 trial (RDD). Contemporary Clinical Trials, 150, 107816. https://doi.org/10.1016/j.cct.2025.107816

Authors:

Matisyahu Shulman

Sarah Meyers-Ohki

Patricia Novo

Scott Provost

Kaitlyn Ohrtman

Paul Van Veldhuisen

Neal Oden

Michael Otterstatter

Genie L Bailey

David Liu

John Rotrosen